Health Canada authorizes DAYVIGO (lemborexant) for treatment of insomnia — MISSISSAUGA, ON, Feb. 4, 2021 - Eisai Limited, the Canadian subsidiary of Eisai Inc., today announced the Canadian authorization and availability of a new non-sedative prescription medication, DAYVIGO™ (lemborexant). Available in both 5 mg and...